192 related articles for article (PubMed ID: 27118251)
1. Cellular and Animal Studies: Insights into Pathophysiology and Therapy of PCOS.
Indran IR; Lee BH; Yong EL
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():12-24. PubMed ID: 27118251
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype.
McAllister JM; Modi B; Miller BA; Biegler J; Bruggeman R; Legro RS; Strauss JF
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):E1519-27. PubMed ID: 24706793
[TBL] [Abstract][Full Text] [Related]
3. A Dietary Medium-Chain Fatty Acid, Decanoic Acid, Inhibits Recruitment of Nur77 to the HSD3B2 Promoter In Vitro and Reverses Endocrine and Metabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome.
Lee BH; Indran IR; Tan HM; Li Y; Zhang Z; Li J; Yong EL
Endocrinology; 2016 Jan; 157(1):382-94. PubMed ID: 26465200
[TBL] [Abstract][Full Text] [Related]
4. miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.
McAllister JM; Han AX; Modi BP; Teves ME; Mavodza GR; Anderson ZL; Shen T; Christenson LK; Archer KJ; Strauss JF
Endocrinology; 2019 Aug; 160(8):1964-1981. PubMed ID: 31184707
[TBL] [Abstract][Full Text] [Related]
5. Human DENND1A.V2 Drives
Teves ME; Modi BP; Kulkarni R; Han AX; Marks JS; Subler MA; Windle J; Newall JM; McAllister JM; Strauss JF
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268539
[TBL] [Abstract][Full Text] [Related]
6. Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome.
Munir I; Yen HW; Baruth T; Tarkowski R; Azziz R; Magoffin DA; Jakimiuk AJ
J Clin Endocrinol Metab; 2005 Aug; 90(8):4852-7. PubMed ID: 15886251
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
Zeng X; Xie YJ; Liu YT; Long SL; Mo ZC
Clin Chim Acta; 2020 Mar; 502():214-221. PubMed ID: 31733195
[TBL] [Abstract][Full Text] [Related]
8. Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome.
Wickenheisser JK; Nelson-DeGrave VL; Hendricks KL; Legro RS; Strauss JF; McAllister JM
J Clin Endocrinol Metab; 2005 Aug; 90(8):4858-65. PubMed ID: 15914525
[TBL] [Abstract][Full Text] [Related]
9. Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome.
Nelson-Degrave VL; Wickenheisser JK; Hendricks KL; Asano T; Fujishiro M; Legro RS; Kimball SR; Strauss JF; McAllister JM
Mol Endocrinol; 2005 Feb; 19(2):379-90. PubMed ID: 15514033
[TBL] [Abstract][Full Text] [Related]
10. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries.
Nelson VL; Legro RS; Strauss JF; McAllister JM
Mol Endocrinol; 1999 Jun; 13(6):946-57. PubMed ID: 10379893
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of DENND1A, a PCOS candidate gene, generates variant 2.
Tee MK; Speek M; Legeza B; Modi B; Teves ME; McAllister JM; Strauss JF; Miller WL
Mol Cell Endocrinol; 2016 Oct; 434():25-35. PubMed ID: 27297658
[TBL] [Abstract][Full Text] [Related]
12. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
Nestler JE
Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
[TBL] [Abstract][Full Text] [Related]
13. Increased protein expression of LHCG receptor and 17α-hydroxylase/17-20-lyase in human polycystic ovaries.
Comim FV; Teerds K; Hardy K; Franks S
Hum Reprod; 2013 Nov; 28(11):3086-92. PubMed ID: 24014605
[TBL] [Abstract][Full Text] [Related]
14. Hepatic manifestations of women with polycystic ovary syndrome.
Chen MJ; Ho HN
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():119-128. PubMed ID: 27107966
[TBL] [Abstract][Full Text] [Related]
15. Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.
Ortega-González C; Luna S; Hernández L; Crespo G; Aguayo P; Arteaga-Troncoso G; Parra A
J Clin Endocrinol Metab; 2005 Mar; 90(3):1360-5. PubMed ID: 15598674
[TBL] [Abstract][Full Text] [Related]
16. Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women.
Medeiros SF; Barbosa JS; Yamamoto MM
J Obstet Gynaecol Res; 2015 Feb; 41(2):254-63. PubMed ID: 25256274
[TBL] [Abstract][Full Text] [Related]
17. The Involvement of Granulosa Cells in the Regulation by Gonadotropins of
Kakuta H; Iguchi T; Sato T
In Vivo; 2018; 32(6):1387-1401. PubMed ID: 30348693
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain.
Hirsch A; Hahn D; Kempná P; Hofer G; Nuoffer JM; Mullis PE; Flück CE
Endocrinology; 2012 Sep; 153(9):4354-66. PubMed ID: 22778212
[TBL] [Abstract][Full Text] [Related]
19. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis.
Wood JR; Nelson VL; Ho C; Jansen E; Wang CY; Urbanek M; McAllister JM; Mosselman S; Strauss JF
J Biol Chem; 2003 Jul; 278(29):26380-90. PubMed ID: 12734205
[TBL] [Abstract][Full Text] [Related]
20. Thecal cell sensitivity to luteinizing hormone and insulin in polycystic ovarian syndrome.
Cadagan D; Khan R; Amer S
Reprod Biol; 2016 Mar; 16(1):53-60. PubMed ID: 26952754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
